Stay updated on Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page.

Latest updates to the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedCore content updated to inform users about funding-related operating status and current NIH Clinical Center openness; version updated from v3.1.0 to v3.2.0.SummaryDifference10%

- Check29 days agoChange DetectedPage update adds a new study status/contacts/locations section and bumps the revision to v3.1.0, while removing the old v3.0.2 tag.SummaryDifference1%

- Check43 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2, indicating a minor release. The 'Back to Top' element was removed, a minor UI change; no other core content changes are indicated.SummaryDifference0.6%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.6%

- Check57 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries.SummaryDifference33%

- Check72 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%

Stay in the know with updates to Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page.